birdflustocks.com
Home
Facts
Idea
Stocks
Brokers
admin
birdflustocks.com
»
admin
admin
SAB Biotherapeutics: SAB-176 Phase 2a study completed, FDA has granted Fast Track designation
By
admin
|
13
Apr, 23
|
Johnson & Johnson: Janssen to Discontinue Pimodivir Influenza Development Program
By
admin
|
3
Sep, 20
|
https://www.americanpharmaceuticalreview.com/1315-News/567852-Janssen-to-Discontinue-Pimodivir-Influenza-Development-Program/
Previous
1
…
3
4
5
